hotspot -WSS

hotspot

author：knowledge 2025-08-11 09:46:08 - browse：6

CHICAGO — A next-generation CAR-T therapy was able to substantially shrink tumors in patients with liver cancer in early clinical data presented Monday at the American Society of Clinical Oncology annual meeting. The study, though preliminary and small with only 24 patients, represents a triad of firsts for one of the trial’s sponsors.

“It’s the first CAR therapy working in liver cancer. First validation of targeting GPC3 as a target. It’s the first validation of our armoring strategy. And it’s the first of many of our visions of CAR therapy in general,” Matt Hellmann, a medical oncologist and early development oncology lead at AstraZeneca, said in an interview.

This abstract, presented by cancer researcher Qi Zhang of Zhejiang University School of Medicine, is yet another significant showing by AstraZeneca at this ASCO. The company had two plenary presentations on its blockbuster lung cancer drug Tagrisso and immunotherapy drug Imfinzi — as well as new results on Enhertu, which AstraZeneca developed with Daiichi Sankyo.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Amylyx's ALS drug launch starts strong. It could be trouble for FDA

WSS

Medicare Advantage overpayments discussion gets experts fired up

Hospital chaplains balance Covid safety with patients’ spiritual needs

In same hospitals, Black patients receive fewer opioids than white patients

American taxpayers paid $1.8 trillion in health care costs in 2022

Emergent cuts jobs, executive role in business shake

American woman, child freed after being kidnapped in Haiti last month

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Physician assistants need a new name. Here's what it should be

What does generative AI mean for health care? We asked experts

At JPM 2024, hospital systems pitch financial strength to investors

Novavax promises a turnaround & Lilly roils the obesity market

Study suggests new cause of Down syndrome: cells linked to aging

What does generative AI mean for health care? We asked experts

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Continuity nursing helped my family in our darkest PICU moments

Drastic changes should bring profitability, startup health insurers say

focus

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Profiling embryos to choose those with higher IQs is almost a reality

Anavex keeps shifting the goalposts in its clinical trials

Naloxone nonprofit donates 200,000 doses after FDA approval

South Korea throws huge K

Wegovy’s successful heart trial raises vital question about weight loss

explore

leisure time

hotspot

focus